Sanofi Expands mRNA Vaccine Efforts By Buying Translate Bio For $3.2B
Translate Bio was already Sanofi's partner in an effort to try to build an mRNA covid vaccine. Separately, reports say the Federal Trade Commission has reluctantly withdrawn a remaining claim in a lawsuit over a so-called pay-to-delay deal with Abbvie.